spironolactone

ApprovedUNKNOWN
0 watching 0 views this week๐Ÿ”ฅ Hot
82
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Hypertension

Conditions

Hypertension

Trial Timeline

Sep 1, 2007 โ†’ Dec 1, 2012

About spironolactone

spironolactone is a approved stage product being developed by Richter Gedeon for Hypertension. The current trial status is unknown. This product is registered under clinical trial identifier NCT00524615. Target conditions include Hypertension.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00524615ApprovedUNKNOWN